Would this explain why RVX pulled out of the kidney conference? That they really don't have any fresh analysis to report, that is significant? Maybe they thought they would have something by March end...but finally threw in the towel when it all came to nothing?
And what does Dr Kalmantar's tweets etc suggest about all this? Are there any smoke signals that we have anything worth adding since the AHA conference?
Iconoclast